“…We perform a retinal evaluation of COVID-19 infected patients admitted with other systemic co-morbidities like cerebral venous thrombosis (CVT), head injury to rule out papilledema, diabetes mellitus, hypertension, mucormycosis, etc. [ 3 ] Mucormycosis patients in the COVID-19 ward are reviewed by the ophthalmology residents on daily basis for monitoring disease progression, new retinal lesions, and response to treatment. All these cases often need a second opinion by a senior resident or retina specialist.…”